Different Surgical Modalities in the Management of Pelvi-ureteric Junction Obstruction

Evaluation of Different Surgical Modalities in the Management of Pelvi-ureteric Junction Obstruction: a Randomized Controlled Trial

Status

Active, not recruiting

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06822270

Enrollment

Registered

2025-02-12

Start date

2024-10-11

Completion date

2025-12-04

Last updated

2025-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvi-ureteric Junction Obstruction

Brief summary

The study compared open pyeloplasty (OP) and laparoscopic pyeloplasty (LP) for treating Pelvi-ureteric Junction Obstruction (PUJO) in 40 patients.

Interventions

PROCEDUREopen surgery

open surgical methods for treating Pelvi-ureteric Junction Obstruction

PROCEDURELaparoscopic Pyeloplasty

minimally invasive laparoscopic techniques.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 60 Years

Healthy volunteers

Inclusion criteria

* Age between 7 months and 60 years. Diagnosed with Pelvi-ureteric Junction Obstruction (PUJO). Glomerular Filtration Rate (GFR) greater than 10 ml/min. Open to both genders.

Exclusion criteria

* Active infection. GFR less than 10 ml/min. Presence of a single kidney. Patients with kidney or multiple congenital anomalies. Pregnancy.

Design outcomes

Primary

Measure	Time frame	Description
Operative Success Rate	3 days	evaluating the effectiveness of each surgical method in resolving PUJO

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026